News

Find News

Filter articles

Showing 121 to 130 of 3607 results

Intubated patients sedative patent the focus of ACS Dobfar suit

US16-12-2021Alex Baldwin

Sun Pharmaceutical has been sued by ACS Dobfar subsidiary InfoRLife and WG Critical Care for allegedly infringing on a patent with its proposed midazolam-an anaesthesia medication.

3M stumbles in litigation strategy over COVID-19 masks

US14-12-2021Muireann Bolger

Multinational 3M has suffered a setback in its litigation campaign against the distributors of N95 masks after a US judge found in favour of arguments made by one of its opponents.

Generics win anti-pay-for-delay bill challenge

US14-12-2021Alex Baldwin

The Association for Accessible Medicines, which represents manufacturers of generics and biosimilars, has succeeded in challenging a California bill that characterises “reverse payment” or “pay-for-delay” patent settlements as anticompetitive and unlawful.

Pharmavite accuses Bausch, GSK of ‘sham’ patent litigation

US13-12-2021Alex Baldwin

Nutritional supplements manufacturer Pharmavite has filed an antitrust suit against Bausch & Lomb and GlaxoSmithKline, claiming that they are filing sham patent litigation related to its “PreserVision” products.

GSK responds to Teva’s ‘skinny’ label rehearing petition

US09-12-2021Alex Baldwin

Following a substantial push from generics companies to reverse the GSK v Teva “skinny” label ruling, GlaxoSmithKilne has added its response to the petition to rehear the case yet again.

Teva loses appeal to invalidate Korlym patent

US09-12-2021Alex Baldwin

Teva Pharmaceuticals has failed to convince the US Court of Appeal for the Federal Circuit that a Corcept Therapeutics method patent for Korlym was invalid.

Mylan gets Fed Circ reprieve in inhaler dispute

US09-12-2021Muireann Bolger

Mylan has been allowed to revisit a decision holding that it infringed patents covering AstraZeneca's inhaler asthma treatment, Symbicort.

Fresenius in patent dispute over hypocalcemia treatment

US07-12-2021Muireann Bolger

Fresenius Kabi is facing a lawsuit by two Pharmasphere subsidiaries over claims that it infringed a patent covering a treatment for hypocalcemia, a condition where the blood sugar level is lower than normal.

Galderma sues Lupin over Oracea generic

US07-12-2021Alex Baldwin

Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea prior to the expiration of key patents.

J&J secures injunction against medical device counterfeiter

US07-12-2021

Johnson & Johnson’s subsidiary Ethicon has obtained a permanent injunction against counterfeiters selling fake versions of Surgicel, an absorbable haemostat used to control bleeding during surgery.

Showing 121 to 130 of 3607 results

LSIPR